-
-
11/03/2015 12/03/2015 America/Toronto American Conference Institute’s 15th Advanced Forum on Fraud & Abuse in the Sales and Marketing of Medical Devices American Conference Institute’s 15th Advanced Forum on Fraud & Abuse in the Sales and Marketing of Medical Devices
March 11 – 12, 2015
Omni Parker House, Boston, MA
Please visit https://staging.americanconference.com/fraud-abuse-in-the-sales-and-marketing-of-medical-devices-743l15-sta/ for more information and updates. Omni Parker House, Boston, MA true DD/MM/YYYY 1440 use-title -
-
-
11/03/2015 12/03/2015 America/Toronto American Conference Institute’s 15th Advanced Forum on Fraud & Abuse in the Sales and Marketing of Medical Devices American Conference Institute’s 15th Advanced Forum on Fraud & Abuse in the Sales and Marketing of Medical Devices
March 11 – 12, 2015
Omni Parker House, Boston, MA
Please visit https://staging.americanconference.com/fraud-abuse-in-the-sales-and-marketing-of-medical-devices-743l15-sta/ for more information and updates. Omni Parker House, Boston, MA true DD/MM/YYYY 1440 use-title -
Understanding and Adapting to New Guidance Regarding the Parameters of Conversation and Dissemination of Information Regarding Off- Label Use of Medical Devices
Anne K. Walsh
Director
Hyman, Phelps & McNamara PC
Darren W. Alch
Vice President, General Counsel & Compliance Officer
Cyberonics, Inc.
- What the FDA Draft Guidance means for medical device promotion
- Best practices to update your salesforce training program
- Necessary adjustments to be made to your controls for your outside contracted sales team
- When, where, and how you can distribute medical publications
- Does the First Amendment still protect that right to distribute as it was deemed in WLF v. Friedman?
- How does this translate overseas?
- Managing your salesforce and FCA exposure
- What happens when your sales team instructs providers to utilize a device in a context that can lead to overbilling?
- Analyzing the consequences of Medtronic Spine and the kyphoplasty settlements
- Balancing that fine line of medical device sales and playing doctor
- Warranty issues
- What can we expect from promised FDA further guidance?